Transcript Highlights:

• Half of products on the market today are not actually authorized by the FDA, and the majority of products
• actually<00:04:20.400> authorized<00:04:20.959> by<00:04:21.199> the<00:04:21.440> FDA
• <00:04:22.560> and<00:04:22.800> the actually authorized by the FDA and the actually
• authorized by the FDA and the majority<00:04:23.440> of<00:04:23.759> products<00:04:24.240

Keywords: 958, all

Summary: The task force opened with a moment of silence for the Louisville UPS plane tragedy, approved the October 15 minutes, and reminded members to submit policy recommendations before the December 16 meeting, when the group will discuss its report to LRC. The first informational presentation, from the Department for Public Health, focused on youth vaping. Elizabeth Good and Julie Brooks cited a recent Surgeon General report warning that youth vaping can harm brain development, mental health, lungs, asthma, and hormones, and noted Kentucky survey data showing 8.7% of students reported daily vaping and 19.7% used vaping products in the prior 30 days. They described prevention and cessation resources including Catch My Breath, I Can End the Trend, Not on Tobacco, My Life, My Quit, Quitline services, and the Kentucky TRUST retailer education program, which trained 3,371 individuals in 2024 and distributed 253 Tobacco 21 toolkits. The next presentation came from Kentucky ABC on implementation of SB 100, which created the division of tobacco, nicotine, and vapor product licensing. Commissioner Scotty Tracy and Jamar Carter said all retailers selling tobacco, nicotine, or vapor products must be licensed, regulations were filed October 31, 2025, and the online application portal is live. In response to questions about sales to minors, they said violations carry escalating fines for clerks and owners, with a fourth violation resulting in no license renewal for two years and unpaid fines also blocking renewal. They said complaints can be submitted through the portal, by phone, or on the ABC website, and enforcement investigates tips and may use underage compliance checks. The committee then heard from Kim McKenna Johnson of One Cross Community Health, who argued for a “deficiency-first” and holistic approach to care centered on nutrition, lifestyle, and targeted supplementation. She said her clinic serves more than 7,000 patients in Taylor and Marion counties and described a model that includes primary care, behavioral health, functional medicine, addiction recovery, and chronic care. She cited Kentucky health rankings, claimed nutritional deficiencies cost the state billions, and said many children are overprescribed while undernourished. She urged broader insurance coverage for nutritional testing and supplements, rural demonstration grants, and Medicaid pilots for clinically prescribed supplements. Members asked about testing costs, dietitian support, long-term cost savings, compliance, and whether medications are often used to prevent damage from noncompliance; the presenter said the lab tests are generally covered, supplements are the main cost barrier, and seeing lab results can improve family buy-in. No votes were taken during the meeting.

Transcript Highlights:

• If they're truly medicine, they should be treated like medicine under FDA authority, not freely available
• After legalization, vape shops appeared with products that were not FDA approved and may contain unknown
• The FDA warns that 10 milligrams of synthetic THC can cause psychosis. Again, 3,000 milligrams.
• If these products are considered medicine, then the FDA should be the sole authority in regulating them

Bills: SB 3, HB28, SB3

Keywords: flash flood, flood warning, outdoor warning siren, emergency alert, disaster preparedness, flood mitigation, Hill Country floods, Texas Water Development Board, municipalities, counties, local government mandate, public safety, grant program, backup power, weather siren, emergency management, flood-prone area, warning system, hemp regulation, consumable products

Transcript Highlights:

• if I recall correctly, was he at the FDA if I recall correctly, was he did<09:30:28.880> tests
• NASA, NOAA, FDA, NIST, they're all doing great work.
• NASA, NOAA, FDA, NIST, they're all doing great work.
• NASA, Noah, FDA, in the United States.
• NASA, Noah, FDA, NIST,<09:35:31.840> they're<09:35:32.080> all<09:35:32.320> doing

Keywords: U.S. House of Representatives Floor Proceedings on Wednesday, September 17, 2025, 1012, house, all

Transcript Highlights:

• He guessed that the current language may have been a carve-out around the time the FDA Food Code was
• guessed that, based on the way the law is written, at some point lawmakers probably wanted to adopt the FDA
• At some point, they wanted to probably adopt the FDA Food Code, which has a specific provision that you

Keywords: 928, house, all

Summary: The Solid Waste Subcommittee met to discuss proposed amendments to HB 171 and HB 215. For HB 171, Representative Gerna outlined technical changes to a landfill moratorium bill: DES would be allowed to accept applications only to review them for completeness, a notwithstanding clause would override automatic approval timing rules, the word “fully” would be removed, and an unnecessary reference to perennial water bodies would be deleted. Members raised concern about whether applications deemed complete during the moratorium would still have to comply with later changes in law or rule. Director Mike Whap of DES said applicants would likely need to amend applications if policy changes occurred, and suggested the bill could explicitly state that later changes apply to pending applications. The subcommittee generally supported the revised language and agreed the amended bill could go directly to executive session, though one member said the underlying legislation was ill-advised but preferred the amended version over the original. The committee then turned to HB 215, which would create a two-stage landfill siting review centered on a “net public benefit” determination before full technical review. Representative Gerna explained that the amendment would define net public benefit, require an independent third-party assessment paid for by the applicant, and set up a process for selecting the contractor from a list submitted by the applicant, with DES and the host community involved and the commissioner choosing if no agreement is reached within 60 days. Members asked how “host community” would be defined; DES said it would generally mean the municipal governing body, though that body could appoint others. The amendment also broadened the factors considered in both harms and benefits, including human health, property values, tourism, recreation, wildlife, local economic benefits, and infrastructure improvements. The discussion also added a provision directing DES to consult with the Department of Transportation, the Department of Business and Economic Affairs, and the Department of Natural and Cultural Resources as needed when reviewing the third-party assessment. Director Whap said interdepartmental consultation is normal and that DES would likely adopt rules to guide the process. Members questioned whether the new framework would be too vague or burdensome for applicants, but Whap said it would not be designed to stack the deck against applicants and that the process should provide clearer, more balanced criteria. No votes were taken during the meeting, and the subcommittee appeared to continue refining the amendment language before further action.

Transcript Highlights:

• And we know what our FDA is an October. We have projections and are usually in line with that.

Transcript Highlights:

• So the FDA does not support that. >> Thank you. A quick brief question.

Transcript Highlights:

• I cite the Natalie trial that led to that drug's FDA approval for that indication.

Bills: HB712, HB722, HB946, HB1687, HB1809, HB1899, HB2528, HB2583, HB2741, HB2750, HB3021, HB3150, HB3265, HB3658, HB3812, HB3960, HB4392, HB4432

Keywords: prostate cancer, health benefit plans, insurance coverage, cost sharing, preventive health care, auto insurance, total loss evaluation, disclosure, insurance materials, vehicle appraisal, HB 946, Texas Insurance Code, automobile insurance claims, oral release, written release, settlement agreement, claim release, property damage, bodily injury, psychological injury

Transcript Highlights:

• In 2019, nationally, the FDA labeled Walgreens the worst offending pharmacy chain, reporting that up

Summary: The Assembly Business and Professions Committee heard a long agenda of licensing, health care, and workforce bills. Measures discussed included AB 957, which would prohibit tobacco sales in licensed pharmacies; AB 447, which would allow patients to take home certain unopened medications started in emergency rooms; AB 427, joining the Social Work Licensure Compact; AB 667, allowing interpreters for certain licensing exams; AB 742, prioritizing descendants of slaves in licensing review; AB 873, changing infection-control training timing for dental assistants; AB 360, requiring a report on menopause education for physicians; and AB 1175, modernizing CPA licensure requirements and mobility. Testimony generally emphasized public health, access to care, workforce shortages, language access, and economic opportunity, while opposition or concerns focused on implementation, worker protections, compact authority, and constitutional issues in AB 742. Several bills drew broad support from sponsors, professional associations, and advocacy groups. AB 957 was backed by cancer and pharmacy advocates and pharmacists who said pharmacies should not sell tobacco; AB 447 was supported by emergency medicine and hospital representatives as a way to reduce waste and help patients leave with needed medication; AB 427 drew support from social work and mental health groups but concerns from AFSCME about standards and displacement; AB 667 was supported by immigrant-rights and community groups, with questions about whether translated exams would be preferable to interpreters; AB 360 received extensive support from women’s health advocates and medical groups, and opposition from CMA and ACOG was removed after amendments; and AB 1175 was supported by the Board of Accountancy and CPA groups as a way to expand the pipeline and improve mobility. The committee took votes after quorum was established. AB 360, AB 427, AB 447, AB 667, AB 873, AB 1175, and AB 742 were all approved and sent to their next committees, with AB 742 going to Judiciary and AB 1175 to Appropriations. AB 957 was initially held on call, then later passed after additional votes were recorded. The consent calendar bills AB 375, AB 1107, and AB 1496 were also approved. Most measures passed on largely party-line or near-unanimous votes, with some members not voting on certain items during the roll calls.

Transcript Highlights:

• The FDA just started doing some regulation, but most of these products are illegal.

Bills: HF2779, HF1645, HF1885, HF1289, HF1534, HF2707, HF1675, HF3046

Keywords: health care transparency, ownership disclosure, control reporting, health care consolidation, private equity, management services organization, MSO, provider organization, health insurer, pharmacy benefit manager, hospital system, affiliate reporting, financial disclosure, public reporting, market concentration, horizontal consolidation, vertical consolidation, health care ownership, corporate practice, health care regulation

Transcript Highlights:

• And yes, it is a June 30 in 2019 Moderna Biontech recognizing the FDA classified mrna as gene therapy

Keywords: 999, senate, all

Transcript Highlights:

• And you can go check with the FDA on that. uh not fully correct. uh not fully correct.
• <03:44:15.320> check<03:44:15.600> with<03:44:15.760> the<03:44:15.920> FDA
• you can go check with the FDA on that. you can go check with the FDA on that.
• While the FDA is looking at alternative testing methods, those are not commercially available at this

Keywords: 1189, house, all

Transcript Highlights:

• So just to clarify earlier, OIC is by the FDA approval specifically for diabetic drugs.
• Wegovy has now a secondary FDA approval for cardiovascular indications; those are covered.
• /c><01:30:29.040> now<01:30:29.280> a<01:30:29.760> secondary<01:30:30.760> FDA
• medications wovi has now a secondary FDA medications wovi has now a secondary FDA approval<01:30

Keywords: 1191, senate, all

Transcript Highlights:

• Just recently, the FDA approved Moderna's M-Nex spike without a single placebo-controlled trial.
• Many vaccines list adverse reactions like these on the FDA package inserts.
• And also that pharma has undue influence over the FDA and the CDC.

Keywords: 995, all

Summary: The Joint Committee on Public Health held a hearing on several vaccination-related bills, including proposals to eliminate non-medical or religious exemptions for school immunizations (notably H. 2554 and S. 1557), a bill to require or improve reporting and administration of immunization data and exemptions (described as the Community Immunity Act, S. 1618), and H. 2431, which would prohibit COVID-19, mRNA, or gene-altering vaccine requirements. The committee also heard testimony on H. 2463, which would classify funeral directors as public health workers for vaccine-priority purposes during emergencies. The chair reviewed testimony rules and repeatedly asked speakers to keep comments orderly and brief so the committee could hear as many people as possible. No votes were taken during the hearing. Testimony on H. 2554 and S. 1557 was sharply divided. Pediatricians, infectious disease specialists, public health advocates, and groups such as the Massachusetts Chapter of the American Academy of Pediatrics, Massachusetts Medical Society, March of Dimes, Massachusetts Families for Vaccines, and several parents supported eliminating religious exemptions, arguing that vaccination protects medically vulnerable children and adults, improves herd immunity, and helps prevent outbreaks of measles, pertussis, and other diseases. They cited local school data showing pockets of lower coverage and incomplete reporting, and several speakers referenced outbreaks in other states and the need for stronger, more consistent reporting and exemption management. Opponents argued the bills would infringe on religious freedom and parental rights, force families to choose between faith and education, and unfairly target a small number of families; some also said Massachusetts already has high vaccination rates and that the real issue is incomplete data or the gap population rather than religious exemptions. H. 2431 drew testimony from supporters who said COVID-era mandates caused job losses, privacy concerns, and harm, and that the bill would prevent future requirements for COVID, mRNA, or gene-altering vaccines in schools, workplaces, and public settings. Supporters described personal experiences with alleged vaccine injury or mandate-related hardship. H. 2463 was supported by the Massachusetts Funeral Directors Association, which argued funeral directors work in infection-facing settings and should be eligible for vaccine priority during public health emergencies. The hearing featured extensive public testimony but no committee action beyond hearing the bills and taking questions from members.

Transcript Highlights:

• have recently turned to compounded versions of weight-loss shots, which are not, and I repeat, not FDA
• advertising of compounded drugs be truthful and clearly state that this product is a compounded drug and is FDA
• place right now is that when you go to social media and when people are buying these drugs, they're not FDA

Summary: The Assembly convened, established a quorum, and proceeded through a large House of Origin floor file, with the Speaker repeatedly urging members to be at their desks and keep support bills brief. Early actions included dispensing with the journal, re-referring AB 2285 to the Banking and Finance Committee, and then taking up dozens of third-reading items, with many bills passed by voice or recorded vote and others passed temporarily or retained on file. The floor debated and passed a wide range of measures on land use, housing, labor, public safety, health care, utilities, taxation, and consumer protection. Among the bills approved were measures on land surveyor review (AB 1933), nurse midwife access for pregnant and postpartum patients (AB 1696), historic-district transit zoning flexibility (AB 2415), EV charging infrastructure fees and timelines (AB 1820), foreclosure bidding protections (AB 1957), tribal cannabis commerce (AB 2506), outdoor advertising permitting (AB 2024), commercial building permit timelines and third-party plan checkers (AB 2418), DUI penalties (AB 1685 and AB 1687), utility rate transparency (AB 1715), CalWORKs work-penalty changes (AB 1755), dynamic electricity rates (AB 1787), interior designer licensure (AB 1796), compost labeling and contamination rules (AB 1812), modular housing standardization (AB 1815), small claims limits for businesses (AB 1827), Native American Day as a paid state holiday (AB 1841), hospital staffing and maternity access bills (AB 1868 and AB 1882), protective orders tied to release dates (AB 1889), and a series of public health, missing persons, and teacher credentialing measures later in the file. Several high-profile bills drew extended debate. AB 2624, expanding Safe at Home privacy protections to immigrant service providers, prompted sharp disagreement over free speech and alleged limits on online posting, but supporters said it protected workers facing threats and doxing; it ultimately passed 49-19. AB 2023, creating a framework for regulating AI chatbots used by children, was framed as a child-safety measure after testimony about chatbot-related harms and suicide risks, and passed 58-8. Other notable votes included AB 2208 on Medi-Cal protections against federal cuts, AB 2299 on CalFresh/SNAP losses, AB 2115 apologizing to California Native peoples for historic state harms, and AB 2311 on public hospital physician employment; the transcript ends as the Assembly continues working through the remaining file.

Transcript Highlights:

• will this legislative change interact with federal regulations and oversight from agencies like the FDA
• So you don't believe that the FDA and federal laws are capable of doing that? No.
• You don't believe that the FDA and federal laws are capable of doing that? No.

Summary: The House convened, established a quorum, heard an invocation and pledges, and approved several routine motions, including excuses for absent members, permission for committees to meet while the House was in session, and postponements of some bills. The chamber also received a Senate message listing measures passed by the Senate and adopted a memorial resolution honoring the 21 victims of the Robb Elementary School shooting in Uvalde, with remarks entered into the House Journal after a moment of silence. The House then took up a long third-reading calendar and passed a series of Senate bills on topics including criminal justice and corrections sunset provisions (SB 2405, 2406, 2407), election equipment testing (SB 2166), electric grid reliability and attack-preparedness exercises (SB 2148), firefighter collective bargaining (SB 777), DFPS and foster care procedures (SB 1141 and SB 1398), Medicare durable medical equipment billing (SB 1330), property tax administration (SB 1453), probate cleanup and record transfers (SB 1448 and SB 1839), mental health filing procedures (SB 53), school residency for children in safety placements (SB 226), diabetes-related amputation study (SB 1677), rapid DNA analysis (SB 1723), utility rate transparency and capacity cost recovery (SB 1664 and SB 1856), community supervision eligibility (SB 552 postponed), and other measures. Several bills passed with broad support, while others drew notable opposition and narrower margins, including SB 777, SB 2137, SB 2111, SB 1677, SB 1936, SB 1453, and SB 38. Two bills drew especially extensive debate. SB 2148, dealing with electricity supply chain reliability and tabletop exercises for critical facilities, was discussed as a grid-security measure aimed at coordinating utilities, law enforcement, ERCOT, and the PUC in the event of physical attacks; it passed unanimously. SB 1936, changing how LSD is measured for criminal prosecution from dosage-based to weight-based calculations, prompted extended discussion about lab consistency, carrier mediums, and fairness in charging, with supporters saying it would help crime labs and law enforcement and opponents warning it could distort penalties depending on the medium used; it passed 108-26. The House also passed SB 36, creating a Homeland Security Division within DPS, after questions about overlap with TDEM and the cost of adding personnel. Late in the day, the House debated SB 38 on eviction procedures, with supporters saying it targeted squatters and streamlined removal of unauthorized occupants, and opponents arguing it would make evictions too easy and worsen homelessness; it passed 85-44. The chamber also began debate on SB 37, a major higher-education governance bill that would expand governing-board oversight of curriculum, hiring, and faculty senates; members raised concerns about academic freedom, faculty governance, and the impact on humanities programs, and debate was still underway at the end of the transcript.

Transcript Highlights:

• representative<00:19:34.240> Hansen<00:19:34.880> uh<00:19:35.280> so<00:19:35.679> FDA
• <00:19:36.159> would<00:19:36.280> be representative Hansen uh so FDA would be representative
• Hansen uh so FDA would be who<00:19:36.760> regulates<00:19:37.400> the<00:19:38.120><

Bills: HF601, HF271, HF1101, HF979

Keywords: agriculture, depredation compensation, livestock, crop damage, elk, wolves, wildlife management, skills path program, career and technical education, CTE, dual credit, postsecondary options enrollment, apprenticeship, apprenticeship readiness, dual training, work-based learning, career pathways, skilled trades, workforce development, high school to career

Transcript Highlights:

• For the first time, the FDA has approved disease-modifying treatments for Alzheimer's, real progress
• This year also, the first blood test to detect Alzheimer's was cleared by the FDA, which is a huge step

Keywords: 995, all

Summary: The committee on Economic Development held a hearing on the DRIVE Act, a proposal to invest $400 million in Massachusetts research and innovation without new taxes. Governor Healey and administration officials said the bill would direct $200 million to public higher education research and regional partnerships and $200 million to a research funding pool for hospitals, universities, and other institutions, with the goal of retaining talent, leveraging private and philanthropic dollars, and offsetting major federal R&D cuts. They argued that research is a core economic engine for the state, supporting jobs across labs, construction, services, and surrounding businesses, and said the bill would help protect the Commonwealth’s tax base and competitiveness during a period of federal uncertainty and cuts to SNAP, Medicaid, and other programs. Committee members raised concerns about whether Fair Share surtax dollars should instead be used for K-12 and other community needs, whether the proposal is enough given the scale of lost federal grants, and how the money would be allocated. The governor responded that the funds are one-time surplus dollars, that most surtax revenue already supports education, and that the bill is meant as a bridge to stabilize public higher education and research. She also said the legislation includes a review board and could support a revolving or matched-fund approach in some cases. Several members pressed for more detail on selection criteria, future funding, and whether private companies and large endowments should contribute more. University of Massachusetts leaders and researchers testified that federal grant cancellations and delays are already causing layoffs, furloughs, rescinded admissions, and lost research capacity. UMass officials said the bill would help preserve faculty, postdocs, graduate students, and research programs in medicine, climate science, marine science, Braille instruction, and AI decision-making. They emphasized that the funding should be merit-based and that the state needs to act quickly to prevent talent from leaving Massachusetts. Business, labor, and industry groups, including MassBio, the Massachusetts Taxpayers Foundation, AIM, the AFL-CIO, and Building Trades, supported the bill, saying it would protect jobs, sustain the innovation ecosystem, and reinforce Massachusetts’ national leadership in research and life sciences. No vote was taken in the hearing.

Transcript Highlights:

• something they've already been able to do, just making it clear in the law to kind of match some of the FDA
• something they've already been able to do, just making it clear in the law to kind of match some of the FDA

Summary: The Administrative Rules Subcommittee reviewed a long agenda of agency rules, with most items approved without objection after brief presentations and no public comment. Early items included Department of Energy and Environment rules on landfill post-closure trust fund spending thresholds and liquefied petroleum gas standards, DFA’s electronic odometer disclosure rule, and several Department of Health rules covering ionizing radiation, mobile home and RV parks, lead-based paint, counseling board revisions, hearing instrument dispensers, athletic training, dental examiners, nursing, pharmacy, medical board, speech-language pathology and audiology, radiologic technology, massage therapy, community health workers, doula certification, and cosmetology/body art. Most of these changes were described as updates to match recent acts, federal standards, compact participation, fee adjustments, or cleanup/clarification, and the committee repeatedly approved them without objection. A substantial portion of the meeting focused on the Arkansas State Board of Nursing’s broad set of rule changes implementing multiple 2025 acts. Those changes included creating a dialysis patient care technician registry, updating contact information requirements, expanding APRN authority to delegate certain tasks, clarifying death certificate and pronouncement authority, allowing substitution of therapeutically equivalent medications, permitting purchase of compounded products, and updating certified medication assistant rules and training standards. Members asked detailed questions about the meaning of therapeutically equivalent substitutions, delegation limits, compounded products, and how often medication lists would be updated; the board said it would review rules annually and use future rulemaking as needed. The committee also approved new nursing rules for declaratory orders and the new dialysis registry. The Department of Education’s rules drew the most discussion, especially the Arkansas Children’s Educational Freedom Account Program. The department said the revisions, based on Act 920 of 2025, were intended to add guardrails, clarify eligible expenses, and streamline approvals. Changes included defining core educational expenses, limiting sports-related spending, adding an intentional misuse standard, restricting certain technology purchases and requiring extra justification over $1,000, capping carryover funds at $8,500, and creating a reconsideration process for denied expenses. Members raised concerns about oversight, appeal timelines, sports equipment, provider credentialing, and whether the rules were too restrictive; department officials said the rules were meant to protect taxpayer funds while preserving flexibility, and they noted the program had received extensive public comment. The committee also approved Education rules for scholarships, residency classification, teacher programs, accelerated learning, and graduate medical education, as well as Labor and Licensing rules on wage and hour standards, boiler rules, motor vehicle commission requirements, professional wrestling regulation, appraiser qualifications, and military recruiting incentives.

Transcript Highlights:

• biological products, I'm going to let the pharmacy folks explain what those are to you, but it's an FDA-defined
• However, it's very well defined what a biological product is by the FDA.

Keywords: 908, all

Summary: The committee first took up Senate Bill 2401, which would require physicians to complete continuing education on nutrition and metabolic health as part of the state’s rural health transformation effort. HHS supported the bill, saying it would help physicians better address chronic disease and preserve federal grant points tied to the state’s application. A member of the public also testified in favor, arguing that better nutrition education could improve diabetes outcomes and reduce costs. The committee then adopted an amendment to add the Board of Occupational Therapy Practice to the background-check statute so the occupational therapy compact could proceed, and it passed the bill as amended on a roll call vote. The committee next heard House Bill 1621, which would require the Presidential Fitness Physical Fitness Test in elementary, middle, and high school physical education courses. HHS said the bill was part of the rural health transformation application and could help preserve federal funding, but members raised many questions about the test’s criteria, adaptive options for students with disabilities, equipment needs, and whether the bill should apply to non-public schools. Senator Clemens offered an amendment to limit the requirement to public schools, but it failed. Senator Hogan then offered an amendment to clarify exemptions and allow DPI to align implementation with federal guidance; that amendment passed. A further amendment adding language allowing DPI to establish criteria for and exceptions to the test also passed. The committee then approved the bill as amended on a roll call vote. The committee also considered House Bill 1622, which joins North Dakota to the physician assistant licensure compact. HHS said the compact would improve access to care, especially in rural areas, support military families, and help preserve rural health transformation funding. Members noted the compact had been discussed in a prior session and that many earlier concerns had been resolved. After brief discussion about the compact process and its consistency with other interstate compacts, the committee voted to do pass the bill. Finally, the committee began Senate Bill 2402, which expands pharmacists’ prescriptive authority and therapeutic substitution powers. HHS and the Board of Pharmacy supported the bill as a way to improve access to care and maintain rural health transformation funding. Senator Roers introduced a detailed amendment negotiated with the Board of Medicine and Board of Pharmacy to narrow and clarify the bill, including notification requirements, limits on certain drug categories, and patient-protection language for therapeutic substitution. The Board of Pharmacy then testified in support of the broader bill and explained the CLIA-waived testing provisions and the repeal of the older, narrower pharmacist-testing language. The hearing and amendment discussion were still underway when the transcript ended.

Transcript Highlights:

• Mental health conditions have safe, affordable access to innovative treatment upon FDA approval.
• bill essentially directs the DSHS Commissioner to prioritize the rescheduling. ...substances that the FDA

Bills: HB200, HB541, HB1803, HB30, HB175, HB249, HB721, HB851, HB897, HB 1128, HB1904, HB1916, HB5560, HB3071, HB5627, HB5435, HB3913, HB2921, HB2695, HB2688, HB3045, HB3483, HB3673, HB4213, HB4226, HB783, HB4373, HB4735, HB5155, HB5057, HB4984, HB4944, HB4813, HB5339, HB5196, HB5033, HB4853, HB3486, HB4211, HB74, HB4670, HB4730, HB4743, HB4603, HB4463, HB3892, HB4139, HB4752, HB4520, HB4517, HB4486, HB4437, HB4426, HB4396, HB4263, HB3487, HB3418, HB2284, HB2266, HB2229, HB4912, HB2189, HB4506, HB5269, HB5224, HB5195, HB3317, HB4166, HB3947, HB3358, HB3370, HB4438, HB3745, HB3602, HB3697, HB2001, HB1968, HB3371, HB3909, HCR7, SB1744, SB1364, SB1316, HB2026, HB3302, HB3368, HB1639, HB5652, HB4655, HB5654, HB5658, HB5656, HB4894, HB4996, HB5088, HB5650, HB4464, HB3751, HB5665, HB5661, HB 1237, HB2802, HB5437, HB2703, HB5666, HB5667, HCR113, HCR86, SB2196, SB463, SB856, SB1245, SB1169, SB509, SB985, SB305, SB552, HB1535, HB 123, HB1804, HB426, HB1773, HB1871, HB2035, HB2492, HB1411, HB4753, HB4666, HB4529, HB1499, HB1610, HB2028, HB1506, HB886, HB3546, HB796, HB223, HB3556, HB2448, HB4638, HB 111, HB180, HB 1027, HB 1178, HB610, HB 1277, HB1615, HB1620, HB5342, HB4885, HB4751, HB4530, HB4488, HB2149, HB2071, HB2282, HB2248, HB2243, HB2522, HB2310, HB2513, HB2300, HB1902, HB1813, HB3719, HB4284, HB3743, HB3778, HB5153, HB5147, HB4877, HB4850, HB3261, HB3005, HB3033, HB2849, HB2967, HB3531, HB1768, HB333, HB2914, HB2613, HB3717, HB3704, HB2697, HB3801, HB3099, HB3488, HB3477, HB3466, HB3396, HB3469, HB2594, HB2776, HB2564, HB2298, HB5331, HB5646, HB5247, HB5323, HB4384, HB3896, HB4014, HB3627, HB3594, HB2524, HB510, HB561, HB5111, HB5446, HB 1181, HB3963, HB2785, HB1661, HB2460, HB200, HB541, HB1803, HB30, HB175, HB249, HB721, HB851, HB897, HB 1128, HB1904, HB1916, HB5560, HB3071, HB5627, HB5435, HB3913, HB2921, HB2695, HB2688, HB3045, HB3483, HB3673, HB4213, HB4226, HB783, HB4373, HB4735, HB5155, HB5057, HB4984, HB4944, HB4813, HB5339, HB5196, HB5033, HB4853, HB3486, HB4211, HB74, HB4670, HB4730, HB4743, HB4603, HB4463, HB3892, HB4139, HB4752, HB4520, HB4517, HB4486, HB4437, HB4426, HB4396, HB4263, HB3487, HB3418, HB2284, HB2266, HB2229, HB4912, HB2189, HB4506, HB5269, HB5224, HB5195, HB3317, HB4166, HB3947, HB3358, HB3370, HB4438, HB3745, HB3602, HB3697, HB2001, HB1968, HB3371, HB3909, HCR98, HCR92, HCR126, HCR7

Keywords: juvenile offenders, parole eligibility, youth justice, criminal justice reform, inmate rehabilitation, direct patient care, healthcare, physicians, medical services, insurance regulation, dentist, dental hygienist, interstate practice, licensure, compact privilege, public health, military members, disaster relief, tax rates, local government